Larimar Therapeutics (LRMR) Enterprise Value: 85.64M

Larimar Therapeutics, Inc. (LRMR)

2.24 -0.03 (-1.32%) USD | NASDAQ | Oct 23, 11:03

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2014. Start Trial.

Date	Value
October 22, 2026	85.64M
October 21, 2026	101.30M
October 20, 2026	103.38M
October 19, 2026	69.98M
October 16, 2026	55.89M
October 15, 2026	56.41M
October 14, 2026	66.85M
October 13, 2026	74.16M
October 12, 2026	112.78M
October 09, 2026	127.39M
October 08, 2026	130.52M
October 07, 2026	135.74M
October 06, 2026	138.87M
October 05, 2026	147.23M
October 02, 2026	157.66M
October 01, 2026	168.10M
September 30, 2026	182.19M
September 29, 2026	176.45M
September 28, 2026	179.58M
September 25, 2026	169.67M
September 24, 2026	195.24M
September 23, 2026	252.13M
September 22, 2026	247.43M
September 21, 2026	248.48M
September 18, 2026	244.30M

Date	Value
September 17, 2026	245.34M
September 16, 2026	258.91M
September 15, 2026	256.83M
September 14, 2026	243.26M
September 11, 2026	257.87M
September 10, 2026	250.56M
September 09, 2026	252.65M
September 08, 2026	274.05M
September 04, 2026	248.48M
September 03, 2026	248.48M
September 02, 2026	252.65M
September 01, 2026	259.96M
August 31, 2026	247.43M
August 28, 2026	267.27M
August 27, 2026	271.44M
August 26, 2026	283.97M
August 25, 2026	282.92M
August 24, 2026	271.44M
August 21, 2026	285.01M
August 20, 2026	282.92M
August 19, 2026	292.32M
August 18, 2026	272.48M
August 17, 2026	299.62M
August 14, 2026	303.80M
August 13, 2026	294.40M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks